CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome

  • Alexander Roberts
  • , Gillian Grafton
  • , Andrew D. Powell
  • , Kristian Brock
  • , Chunlin Chen
  • , Dejian Xie
  • , Jinkun Huang
  • , Shuang Liu
  • , Alison J Cooper
  • , Catherine A Brady
  • , Omar Qureshi
  • , Zania Stamataki
  • , David D Manning
  • , Nicholas A Moore
  • , Bruce J Sargent
  • , Peter R Guzzo
  • , Nicholas M Barnes

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science